Skip to content

Clinical trials

Phase 1/2 Diabetic Retinopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Phase 1/2 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20083
20111
20121
20131
20161
20192
20202
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo4
Boehringer Ingelheim2
Ace Cells Lab Limited1
AsclepiX Therapeutics, Inc.1
Clearside Biomedical, Inc.1
David M. Brown, M.D.1
Federal University of São Paulo1
National Eye Institute (NEI)1
Natureceuticals Sdn Bhd1
Rishi Singh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy15
Diabetes Mellitus4
Retinal Diseases3
Eye Diseases2
Macular Degeneration2
Macular Edema2
Cardiovascular Diseases1
Cataract1
Diabetic Angiopathies1
Pain1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.